311 related articles for article (PubMed ID: 12812355)
1. Efficacy of mefloquine and a mefloquine-artesunate combination therapy for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon Basin of Peru.
Marquiño W; Huilca M; Calampa C; Falconí E; Cabezas C; Naupay R; Ruebush TK
Am J Trop Med Hyg; 2003 May; 68(5):608-12. PubMed ID: 12812355
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of mefloquine and mefloquine-artesunate for the treatment of uncomplicated Plasmodium falciparum malaria in the Amazon region of Bolivia.
Avila JC; Villaroel R; Marquiño W; Zegarra J; Mollinedo R; Ruebush TK
Trop Med Int Health; 2004 Feb; 9(2):217-21. PubMed ID: 15040558
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and tolerability of artesunate plus sulfadoxine-pyrimethamine and sulfadoxine-pyrimethamine alone for the treatment of uncomplicated Plasmodium falciparum malaria in Peru.
Marquiño W; Ylquimiche L; Hermenegildo Y; Palacios AM; Falconí E; Cabezas C; Arróspide N; Gutierrez S; Ruebush TK
Am J Trop Med Hyg; 2005 May; 72(5):568-72. PubMed ID: 15891131
[TBL] [Abstract][Full Text] [Related]
4. Mefloquine pharmacokinetics and mefloquine-artesunate effectiveness in Peruvian patients with uncomplicated Plasmodium falciparum malaria.
Gutman J; Green M; Durand S; Rojas OV; Ganguly B; Quezada WM; Utz GC; Slutsker L; Ruebush TK; Bacon DJ
Malar J; 2009 Apr; 8():58. PubMed ID: 19358697
[TBL] [Abstract][Full Text] [Related]
5. Artesunate and mefloquine given simultaneously for three days via a prepacked blister is equally effective and tolerated as a standard sequential treatment of uncomplicated acute Plasmodium falciparum malaria: randomized, double-blind study in Thailand.
Krudsood S; Looareesuwan S; Silachamroon U; Chalermrut K; Pittrow D; Cambon N; Mueller EA
Am J Trop Med Hyg; 2002 Nov; 67(5):465-72. PubMed ID: 12479545
[TBL] [Abstract][Full Text] [Related]
6. Randomized comparison of chloroquine plus sulfadoxine-pyrimethamine versus artesunate plus mefloquine versus artemether-lumefantrine in the treatment of uncomplicated falciparum malaria in the Lao People's Democratic Republic.
Mayxay M; Khanthavong M; Lindegårdh N; Keola S; Barends M; Pongvongsa T; Yapom R; Annerberg A; Phompida S; Phetsouvanh R; White NJ; Newton PN
Clin Infect Dis; 2004 Oct; 39(8):1139-47. PubMed ID: 15486837
[TBL] [Abstract][Full Text] [Related]
7. Open randomized study of artesunate-amodiaquine vs. chloroquine-pyrimethamine-sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children.
Sowunmi A; Fehintola FA; Adedeji AA; Gbotosho GO; Tambo E; Fateye BA; Happi TC; Oduola AM
Trop Med Int Health; 2005 Nov; 10(11):1161-70. PubMed ID: 16262741
[TBL] [Abstract][Full Text] [Related]
8. Artesunate/mefloquine treatment of multi-drug resistant falciparum malaria.
Price RN; Nosten F; Luxemburger C; van Vugt M; Phaipun L; Chongsuphajaisiddhi T; White NJ
Trans R Soc Trop Med Hyg; 1997; 91(5):574-7. PubMed ID: 9463672
[TBL] [Abstract][Full Text] [Related]
9. Adverse effects of mefloquine for the treatment of uncomplicated malaria in Thailand: A pooled analysis of 19, 850 individual patients.
Lee SJ; Ter Kuile FO; Price RN; Luxemburger C; Nosten F
PLoS One; 2017; 12(2):e0168780. PubMed ID: 28192434
[TBL] [Abstract][Full Text] [Related]
10. [Therapeutic efficacy of a regimen of artesunate-mefloquine-primaquine treatment for Plasmodium falciparum malaria and treatment effects on gametocytic development].
Vásquez AM; Sanín F; Alvarez LG; Tobón A; Ríos A; Blair S
Biomedica; 2009 Jun; 29(2):307-19. PubMed ID: 20128355
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy of artemether-lumefantrine and artesunate-mefloquine for treatment of uncomplicated Plasmodium falciparum malaria in Luang Namtha Province, Lao People's Democratic Republic.
Stohrer JM; Dittrich S; Thongpaseuth V; Vanisaveth V; Phetsouvanh R; Phompida S; Monti F; Christophel EM; Lindegardh N; Annerberg A; Jelinek T
Trop Med Int Health; 2004 Nov; 9(11):1175-83. PubMed ID: 15548313
[TBL] [Abstract][Full Text] [Related]
12. Lack of prediction of mefloquine and mefloquine-artesunate treatment outcome by mutations in the Plasmodium falciparum multidrug resistance 1 (pfmdr1) gene for P. falciparum malaria in Peru.
Pillai DR; Hijar G; Montoya Y; Marouiño W; Ruebush TK; Wongsrichanalai C; Kain KC
Am J Trop Med Hyg; 2003 Jan; 68(1):107-10. PubMed ID: 12557835
[TBL] [Abstract][Full Text] [Related]
13. A randomized, double-blind study on the efficacy and safety of a practical three-day regimen with artesunate and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria in Africa.
Massougbodji A; Kone M; Kinde-Gazard D; Same-Ekobo A; Cambon N; Mueller EA
Trans R Soc Trop Med Hyg; 2002; 96(6):655-9. PubMed ID: 12625145
[TBL] [Abstract][Full Text] [Related]
14. Comparison of chloroquine, sulfadoxine/pyrimethamine, mefloquine and mefloquine-artesunate for the treatment of falciparum malaria in Kachin State, North Myanmar.
Smithuis F; Shahmanesh M; Kyaw MK; Savran O; Lwin S; White NJ
Trop Med Int Health; 2004 Nov; 9(11):1184-90. PubMed ID: 15548314
[TBL] [Abstract][Full Text] [Related]
15. Six-years monitoring the efficacy of the combination of artesunate and mefloquine for the treatment of uncomplicated falciparum malaria.
Wattanakoon Y; Chittamas S; Pornkulprasit V; Kanda T; Thimasarn K; Rojanawatsirivej C; Looareesuwan S; Bunnag D
Southeast Asian J Trop Med Public Health; 2003 Sep; 34(3):542-5. PubMed ID: 15115124
[TBL] [Abstract][Full Text] [Related]
16. An open, randomized trial of three-day treatment with artesunate combined with a standard dose of mefloquine divided over either two or three days, for acute, uncomplicated falciparum malaria.
Silachamroon U; Krudsood S; Thanachartwet W; Tangpukdee N; Leowattana W; Chalermrut K; Srivilairit S; Wilaiaratana P; Thimasarn K; Looareesuwan S
Southeast Asian J Trop Med Public Health; 2005 May; 36(3):591-6. PubMed ID: 16124422
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of chloroquine, sulfadoxine-pyrimethamine, and mefloquine for the treatment of uncomplicated Plasmodium falciparum malaria on the north coast of Peru.
Marquiño W; MacArthur JR; Barat LM; Oblitas FE; Arrunátegui M; Garavito G; Chafloque ML; Pardavé B; Gutierrez S; Arróspide N; Carrillo C; Cabezas C; Ruebush TK
Am J Trop Med Hyg; 2003 Jan; 68(1):120-3. PubMed ID: 12557836
[TBL] [Abstract][Full Text] [Related]
18. New fixed-dose artesunate-mefloquine formulation against multidrug-resistant Plasmodium falciparum in adults: a comparative phase IIb safety and pharmacokinetic study with standard-dose nonfixed artesunate plus mefloquine.
Krudsood S; Looareesuwan S; Tangpukdee N; Wilairatana P; Phumratanaprapin W; Leowattana W; Chalermrut K; Ramanathan S; Navaratnam V; Olliaro P; Vaillant M; Kiechel JR; Taylor WR
Antimicrob Agents Chemother; 2010 Sep; 54(9):3730-7. PubMed ID: 20547795
[TBL] [Abstract][Full Text] [Related]
19. Artesunate and mefloquine in the treatment of uncomplicated multidrug-resistant hyperparasitaemic falciparum malaria.
Price R; Luxemburger C; van Vugt M; Nosten F; Kham A; Simpson J; Looareesuwan S; Chongsuphajaisiddhi T; White NJ
Trans R Soc Trop Med Hyg; 1998; 92(2):207-11. PubMed ID: 9764335
[TBL] [Abstract][Full Text] [Related]
20. Surveillance of the efficacy of artesunate and mefloquine combination for the treatment of uncomplicated falciparum malaria in Cambodia.
Denis MB; Tsuyuoka R; Poravuth Y; Narann TS; Seila S; Lim C; Incardona S; Lim P; Sem R; Socheat D; Christophel EM; Ringwald P
Trop Med Int Health; 2006 Sep; 11(9):1360-6. PubMed ID: 16930257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
